NCT04777643View on ClinicalTrials.gov

Sex Differences in Neural Response to Cannabidiol

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

June 7, 2022

Primary Completion Date

April 27, 2023

Study Completion Date

April 27, 2023

Conditions
CBDNeural Responses
Interventions
DRUG

Cannabidiol

Participants will receive a single 600mg oral dose of Epidiolex (cannabidiol) 2 hours prior to fMRI scanning.

OTHER

Placebo

Participants will receive a single oral dose of placebo 2 hours prior to fMRI scanning.

Trial Locations (1)

06510

Yale School of Medicine, New Haven

All Listed Sponsors
lead

Yale University

OTHER